Practice Guideline
doi: 10.1093/rheumatology/kel216a.
Epub 2006 Aug 28.
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
Affiliations
- PMID: 16940305
- DOI: 10.1093/rheumatology/kel216a
Item in Clipboard
Practice Guideline
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
Rheumatology (Oxford).
2008 Jun.
No abstract available
Comment in
-
Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.Rheumatology (Oxford). 2008 Oct;47(10):1591; author reply 1591. doi: 10.1093/rheumatology/ken322. Epub 2008 Aug 1. Rheumatology (Oxford). 2008. PMID: 18676499 No abstract available.
Similar articles
-
Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.Rheumatology (Oxford). 2008 Oct;47(10):1591; author reply 1591. doi: 10.1093/rheumatology/ken322. Epub 2008 Aug 1. Rheumatology (Oxford). 2008. PMID: 18676499 No abstract available.
-
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.Clin Ther. 2009 Aug;31(8):1737-46. doi: 10.1016/j.clinthera.2009.08.009. Clin Ther. 2009. PMID: 19808132 Review.
-
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.Rheumatology (Oxford). 2010 Nov;49(11):2217-9. doi: 10.1093/rheumatology/keq249a. Epub 2010 Sep 12. Rheumatology (Oxford). 2010. PMID: 20837498 No abstract available.
-
Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?Musculoskeletal Care. 2008 Dec;6(4):233-45. doi: 10.1002/msc.135. Musculoskeletal Care. 2008. PMID: 18702106
-
Management of early rheumatoid arthritis.J Assoc Physicians India. 2007 May;55:355-62. J Assoc Physicians India. 2007. PMID: 17844697 Review.
Cited by
-
Complications of long-term therapy for ANCA-associated systemic vasculitis.Nat Rev Nephrol. 2012 Sep;8(9):523-32. doi: 10.1038/nrneph.2012.107. Epub 2012 Jun 5. Nat Rev Nephrol. 2012. PMID: 22664736 Review.
-
Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases.Rheumatol Int. 2014 Feb;34(2):151-63. doi: 10.1007/s00296-013-2907-9. Epub 2013 Dec 10. Rheumatol Int. 2014. PMID: 24322451 Review.
-
Risk of liver disease in methotrexate treated patients.World J Hepatol. 2017 Sep 18;9(26):1092-1100. doi: 10.4254/wjh.v9.i26.1092. World J Hepatol. 2017. PMID: 28989565 Free PMC article. Review.
-
Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.PLoS One. 2018 Mar 23;13(3):e0194401. doi: 10.1371/journal.pone.0194401. eCollection 2018. PLoS One. 2018. PMID: 29570708 Free PMC article. Clinical Trial.
-
LD-aminopterin in the canine homologue of human atopic dermatitis: a randomized, controlled trial reveals dosing factors affecting optimal therapy.PLoS One. 2014 Sep 25;9(9):e108303. doi: 10.1371/journal.pone.0108303. eCollection 2014. PLoS One. 2014. PMID: 25255447 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
